Successful Liver Transplantation in a Patient With Acute COVID-19 Infection and Acute Liver Failure: A Case Report.
Kristen M Kidson, Jeieung Park, Marthe K Charles, Mahmoud Omar, Mel Krajden, Alissa J Wright, Trana Hussaini, Peter T W Kim, Stephen W Chung, Eric M Yoshida
Author Information
Kristen M Kidson: Department of Anesthesiology and Perioperative Care, Vancouver General Hospital, Vancouver, BC, Canada.
Jeieung Park: Department of Anesthesiology and Perioperative Care, Vancouver General Hospital, Vancouver, BC, Canada.
Marthe K Charles: Division of Medical Microbiology & Infection Control, Vancouver Coastal Health Authority, Vancouver, BC, Canada.
Mahmoud Omar: Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Mel Krajden: Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Alissa J Wright: Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Trana Hussaini: Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
Peter T W Kim: Department of General Surgery, University of British Columbia, Vancouver, BC, Canada.
Stephen W Chung: Department of General Surgery, University of British Columbia, Vancouver, BC, Canada.
Eric M Yoshida: Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Al Minufiyah, Egypt.
Current liver transplantation societies recommend recipients with active coronavirus disease 2019 (COVID-19) be deferred from transplantation for at least 2 wks, have symptom resolution and at least 1 negative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test. This approach does not address patients who require urgent transplantation and will otherwise die from liver failure. We report a successful orthotopic liver transplant (OLT) in a patient with active COVID-19 infection. This is only the second to be reported worldwide and the first in Canada.
